Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Morrell

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
JCI Insight|April 29, 2020
Cholesterol 25-hydroxylase promotes efferocytosis and resolution of lung inflammationJennifer H Madenspacher, Eric D Morrell, Kymberly M Gowdy, et al.
JCI Insight|November 12, 2021
Cross-validation of SARS-CoV-2 responses in kidney organoids and clinical populationsLouisa Helms, Silvia Marchiano, Ian B Stanaway, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Alveolar Immune Profiling Identifies Distinct Subphenotypes of Acute Respiratory FailureEric D Morrell, Ted Liu, Marika Orlov, et al.
American Journal of Respiratory Cell and Molecular Biology|July 1, 2024
PD-L1 and PD-1 Are Associated with Clinical Outcomes and Alveolar Immune Cell Activation in Acute Respiratory Distress SyndromeEric D Morrell, Sarah E Holton, Alice Wiedeman, et al.
American Journal of Respiratory and Critical Care Medicine|October 19, 2018
Identification of Acute Kidney Injury Subphenotypes with Differing Molecular Signatures and Responses to Vasopressin TherapyPavan K Bhatraju, Leila R Zelnick, Jerald Herting, et al.
Critical Care (London, England)|April 20, 2021
Comparison of host endothelial, epithelial and inflammatory response in ICU patients with and without COVID-19: a prospective observational cohort studyPavan K Bhatraju, Eric D Morrell, Leila Zelnick, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 24, 2022
Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illnessEric D Morrell, Pavan K Bhatraju, Neha A Sathe, et al.
Critical Care Explorations|July 18, 2024
COVID-19 Across Pandemic Variant Periods: The Severe Acute Respiratory Infection-Preparedness (SARI-PREP) StudyVikramjit Mukherjee, Radu Postelnicu, Chelsie Parker, et al.
Annals of the American Thoracic Society|August 1, 2025
Research Priorities for Noninvasive Sampling of the Lower Respiratory Tract during Acute Respiratory Failure: An Official American Thoracic Society Workshop ReportWilliam Bain, Aartik Sarma, Luisa Morales-Nebreda, et al.
Critical Care Explorations|January 5, 2023
Angiopoietin-Like4 Is a Novel Marker of COVID-19 SeverityPavan K Bhatraju, Eric D Morrell, Ian B Stanaway, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
JCI Insight|April 29, 2020
Cholesterol 25-hydroxylase promotes efferocytosis and resolution of lung inflammationJennifer H Madenspacher, Eric D Morrell, Kymberly M Gowdy, et al.
JCI Insight|November 12, 2021
Cross-validation of SARS-CoV-2 responses in kidney organoids and clinical populationsLouisa Helms, Silvia Marchiano, Ian B Stanaway, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Alveolar Immune Profiling Identifies Distinct Subphenotypes of Acute Respiratory FailureEric D Morrell, Ted Liu, Marika Orlov, et al.
American Journal of Respiratory Cell and Molecular Biology|July 1, 2024
PD-L1 and PD-1 Are Associated with Clinical Outcomes and Alveolar Immune Cell Activation in Acute Respiratory Distress SyndromeEric D Morrell, Sarah E Holton, Alice Wiedeman, et al.
American Journal of Respiratory and Critical Care Medicine|October 19, 2018
Identification of Acute Kidney Injury Subphenotypes with Differing Molecular Signatures and Responses to Vasopressin TherapyPavan K Bhatraju, Leila R Zelnick, Jerald Herting, et al.
Critical Care (London, England)|April 20, 2021
Comparison of host endothelial, epithelial and inflammatory response in ICU patients with and without COVID-19: a prospective observational cohort studyPavan K Bhatraju, Eric D Morrell, Leila Zelnick, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 24, 2022
Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illnessEric D Morrell, Pavan K Bhatraju, Neha A Sathe, et al.
Critical Care Explorations|July 18, 2024
COVID-19 Across Pandemic Variant Periods: The Severe Acute Respiratory Infection-Preparedness (SARI-PREP) StudyVikramjit Mukherjee, Radu Postelnicu, Chelsie Parker, et al.
Annals of the American Thoracic Society|August 1, 2025
Research Priorities for Noninvasive Sampling of the Lower Respiratory Tract during Acute Respiratory Failure: An Official American Thoracic Society Workshop ReportWilliam Bain, Aartik Sarma, Luisa Morales-Nebreda, et al.
Critical Care Explorations|January 5, 2023
Angiopoietin-Like4 Is a Novel Marker of COVID-19 SeverityPavan K Bhatraju, Eric D Morrell, Ian B Stanaway, et al.
Pageof 14